Elevate your expertise, embrace innovation, and join the global leaders who are transforming the future of bioprocessing. Now in its 18th year, the Bioprocessing Summit unites a global community of...
The journey from a successful lab result to a reliable, GMP-compliant product is rarely a straight line. It's a transition filled with technical hurdles, regulatory pressure, and the constant challenge...
Unexpected particle findings can raise critical questions about product quality, patient safety, and regulatory compliance. Join KBI Biopharma's experts to learn how clinical in-use studies and advanced particle forensics can...
As biologics developers work to improve productivity, maintain product quality, and accelerate development timelines, traditional optimization approaches can sometimes reach a point of diminishing returns. While cell culture processes generate...
The Matrix One West Coast MedTech Forum is a free series of expert roundtables, educational sessions and networking events taking place across California from 18 to 27 August 2026. Designed...
As biologics developers work to improve productivity, reduce development timelines, and manage manufacturing costs, traditional media optimization approaches can become increasingly resource intensive. Predictive modeling is emerging as a complementary...
Nanoparticle programs can stall when early formulation choices fail to hold up through scale-up, tech transfer, and manufacturing. Join leading CDMO experts on August 18 at 11:00 AM ET to...
Oral solid dose programs can run into costly scale-up challenges when early formulation and process decisions aren’t built for long-term manufacturability. Join leading CDMO experts on August 18 at 1:00...
In this webinar we expand on some of the processes most vulnerable to introducing titer variability, as well as strategies to overcome sources of variability when they are unavoidable to...
How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies? Should companies adjust their agency communication strategies...
